Evidence map›Paper›PMID 35931093›Full record

ReviewThe lancet. Psychiatry2022

Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits.

Todd Lencz, Maya Sabatello, Anna Docherty, Roseann E Peterson, Takahiro Soda, Jehannine Austin, Laura Bierut, David Crepaz-Keay, David Curtis, Franziska Degenhardt and 8 more

Open access · greenAbstract readReview
In one paragraph

Review in The lancet. Psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Polygenic scores in psychiatric research and clinical practice.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026
    Article
  3. Patient Perspectives on Psychiatric Polygenic Risk Scores in Reproductive Decision-Making and Polygenic Embryo Screening.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. medRxiv : the preprint server for health sciences · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Polygenic embryo screening: quo vadis?Journal of assisted reproduction and genetics · 2024
    Review
  18. Predicting the direction of phenotypic difference.bioRxiv : the preprint server for biology · 2024
    Article
  19. Genetics for mental health clinicians: a call for a globally accessible and equitable psychiatric genetics education.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 18 institutions in 5 countries.

Todd LenczDivison of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY, USA; Department of Psychiatry, Division of Research, The Zucker Hillside Hospital Division of Northwell Health, Glen Oaks, NY, USA; Institute for Behavioral Science, The Feinstein Institutes for Medical Research, Manhasset, NY, USA. Electronic address: tlencz@northwell.edu.
Maya SabatelloDivision of Ethics, Department of Medical Humanities and Ethics, Columbia University, New York, NY, USA.
Anna DochertyDepartment of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Roseann E PetersonVirginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
Takahiro SodaDepartment of Psychiatry, University of Florida College of Medicine, Gainesville, FL, USA.
Jehannine AustinDepartments of Psychiatry and Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Laura BierutDepartment of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.
David Crepaz-KeayMental Health Foundation, London, UK.
David CurtisUCL Genetics Institute, University College London, London, United Kingdom.
Franziska DegenhardtDepartment of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
Laura HuckinsDepartments of Psychiatry and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Gabriel Lazaro-MunozCenter for Bioethics, Harvard Medical School, Cambridge, MA, USA.
Manuel MattheisenDepartment of Psychiatry, Dalhousie Medical School, Halifax, NS, Canada.
Bettina MeiserPrince of Wales Clinical School, University of New South Wales, NSW, Australia.
Holly PeayGenomics, Bioinformatics, and Translational Research Center, RTI International, Raleigh, NC, USA.
Marcella RietschelDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Consuelo Walss-BassDepartment of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
Lea K DavisVanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.
Columbia University · USDalhousie University · CAFeinstein Institute for Medical Research · USHarvard University · USHeidelberg University · DEIcahn School of Medicine at Mount Sinai · USMental Health Foundation · GBRTI International · USThe University of Texas Health Science Center at Houston · USUniversity College London · GBUniversity of British Columbia · CAUniversity of Duisburg-Essen · DEUniversity of Florida · USUniversity of Utah · USUNSW Sydney · AUVanderbilt University Medical Center · USVirginia Commonwealth University · USWashington University in St. Louis · US

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Polygenic Embryo Screening: Towards Informed Decision-MakingR01HG011711 · NHGRI · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CARMI, SHAI, LAZARO-MUNOZ, GABRIEL · 2021 to 2025
$6.2M
Cross-Population Working Group on Genes and Environment in Major Depression (POP-GEM): Advancing the Understating of Etiology through DiversityR01MH125938 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI Roseann Elizabeth Peterson · 2022 to 2026
$4.2M
Genome-Wide Association Analysis of Suicide DeathR01MH123619 · NIMH · UNIVERSITY OF UTAH · PI DOCHERTY, ANNA R. · 2020 to 2024
$3.2M
Polygenic Risk Scores in Child and Adolescent Psychiatry: Ethical, Clinical, and Legal ImplicationsR01MH128676 · NIMH · BAYLOR COLLEGE OF MEDICINE · PI LAZARO-MUNOZ, GABRIEL, PEREIRA, STACEY · 2021 to 2024
$2.5M
3/7 Psychiatric Genomics Consortium: Advancing Discovery and ImpactR01MH124839 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ANDREASSEN, OLE A, HUCKINS, LAURA MARIANNE · 2021 to 2025
$2.0M
Impact of Psychiatric Genetic Data on Civil Litigation and its Relationship with StigmaK01HG008653 · NHGRI · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI SABATELLO, MAYA · 2015 to 2019
$871k
NCATS NIH HHS UL1 TR002538NHGRI NIH HHS K01 HG008653NHGRI NIH HHS R01 HG011711NIMH NIH HHS R01 MH123619NIMH NIH HHS R01 MH124839NIMH NIH HHS R01 MH125938NIMH NIH HHS R01 MH128676
6 · The paper itself

Abstract

Private companies have begun offering services to allow parents undergoing in-vitro fertilisation to screen embryos for genetic risk of complex diseases, including psychiatric disorders. This procedure, called polygenic embryo screening, raises several difficult scientific and ethical issues, as discussed in this Personal View. Polygenic embryo screening depends on the statistical properties of polygenic risk scores, which are complex and not well studied in the context of this proposed clinical application. The clinical, social, and ethical implications of polygenic embryo screening have barely been discussed among relevant stakeholders. To our knowledge, the International Society of Psychiatric Genetics is the first professional biomedical organisation to issue a statement regarding polygenic embryo screening. For the reasons discussed in this Personal View, the Society urges caution and calls for additional research and oversight on the use of polygenic embryo screening.

Indexed as

Mental DisordersMultifactorial InheritanceCognitionHumansPhenotypeRisk Factors

Identifiers

PMID35931093
PMCPMC9930635
OpenAlexW4289525557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.